111 Shares Outstanding 2018-2024 | YI

111 shares outstanding from 2018 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
111 Annual Shares Outstanding
(Millions of Shares)
2024 9
2023 8
2022 8
2021 8
2020 8
2019 8
2018 5
2017 4
111 Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31 9
2024-09-30 9
2024-06-30 9
2024-03-31 9
2023-12-31 8
2023-09-30 8
2023-06-30 8
2023-03-31 8
2022-12-31 8
2022-09-30 8
2022-06-30 8
2022-03-31 8
2021-12-31 8
2021-09-30 8
2021-06-30 8
2021-03-31 8
2020-12-31 8
2020-09-30 8
2020-06-30 8
2020-03-31 8
2019-12-31 8
2019-09-30 8
2019-06-30 8
2019-03-31 8
2018-09-30 5
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.070B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.557B 53.26
Tempus AI (TEM) United States $9.312B 0.00
Hims & Hers Health (HIMS) United States $9.304B 97.39
Inspire Medical Systems (INSP) United States $4.724B 73.15
IRhythm Technologies (IRTC) United States $4.334B 0.00
Privia Health (PRVA) United States $2.788B 208.91
Enovis (ENOV) United States $1.951B 12.07
Schrodinger (SDGR) United States $1.898B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Phreesia (PHR) United States $1.483B 0.00
Omnicell (OMCL) United States $1.428B 30.80
Azenta (AZTA) United States $1.197B 55.74
10x Genomics (TXG) United States $1.053B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.539B 0.00
Talkspace (TALK) United States $0.527B 313.00
Veradigm (MDRX) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.437B 0.00
TruBridge (TBRG) United States $0.393B 0.00
Claritev (CTEV) United States $0.346B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.221B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
Pulmonx (LUNG) United States $0.144B 0.00
American Well (AMWL) United States $0.114B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.083B 0.00
CareCloud (CCLD) United States $0.074B 3.18
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00